The MarketReader Minute
💊Apellis Soars on Study Results, Illumina and Amgen Gain on Analyst Optimism, Sarepta Slumps on Sales Miss | Biotech Sector Insights
Notable contributors include APLS, ILMN, MRNA, AMGN, and BGNE, all reporting positive returns. APLS and Sobi announced favorable Phase 3 results for pegcetacoplan, demonstrating a significant reduction in proteinuria in patients with specific kidney conditions.